{ "docId": "019dd923-622c-750b-8b9b-a077f08347fa", "docSlug": "4934d687cb38", "documentTitle": "Valeant Pharmaceuticals International (VRX)", "authorId": "01_Pershing_Square", "authorName": "William Ackman", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "activist_investor", "sourceTypeLabel": "Activist investor", "presentationDate": "2015-10-30 00:00:00", "orientation": "landscape", "aspectRatio": 1.3333334, "pageNumber": 16, "pageCount": 39, "prevPage": 15, "nextPage": 17, "slideType": "expose_contradiction", "function": "expose_contradiction", "density": "dense", "nDataPoints": 1, "notes": "The slide uses a direct quote from a legal complaint to undermine the credibility of the subject.", "elementsJson": [ "headline_text", "bullet_list", "quote_block" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-622c-750b-8b9b-a077f08347fa/16", "deckHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa", "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa.json", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-a077f08347fa#slide-16", "components": [ { "bbox": null, "kind": "callout", "text": "R&O / Russell Reitz’s lawsuit against Valeant creates the impression that R&O was not aware of Valeant’s relationship with Philidor / Isolani", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd953-70f7-7334-b228-be2297a9e535", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.92, "x": 0.04, "y": 0.18 }, "kind": "list", "text": "R&O / Russell Reitz's lawsuit against Valeant creates the impression that R&O was not aware of Valeant's relationship with Philidor / Isolani", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "999bd08d-07f5-48cc-b1af-e0ca2672296f", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.03, "w": 0.45, "x": 0.18, "y": 0.29 }, "kind": "paragraph", "text": "R&O Pharmacy LLC Complaint for Declaratory Judgment:", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "834f9a80-ca9e-4817-8526-df7702355480", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.48, "w": 0.75, "x": 0.21, "y": 0.33 }, "kind": "paragraph", "text": "On September 4, 2015, R&O received a letter from Robert Chai-Onn, Valeant's Executive Vice President, Chief Legal Officer and General Counsel. In the letter, which was the first correspondence that R&O had ever received directly from Valeant, Mr. Chai-Onn claimed that R&O, a small licensed California pharmacy, owed Valeant over $69,000,000. However, R&O has never received a single invoice from Valeant in any amount and until September 4 had never received a single demand for payment from Valeant. R&O has requested copies of the invoices, but to no avail. Indeed, it seems that Valeant has no evidence whatsoever to back up its claims. Therefore, R&O believes that one of two things must be true: 1. Valeant and R&O are victims of a massive fraud perpetuated by third parties; or 2. Valeant is conspiring with other persons or entities to perpetuate a massive fraud against R&O and others.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "8bcb1e44-f2e6-46e0-a64e-9605bafe33b0", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "quote", "text": "On September 4, 2015, R&O received a letter from Robert Chai-Onn, Valeant’s Executive Vice President, Chief Legal Officer and General Counsel. In the letter, which was the first correspondence that R&O had ever received directly from Valeant, Mr. Chai-Onn claimed that R&O, a small licensed California pharmacy, owed Valeant over $69,000,000. However, R&O has never received a single invoice from Valeant in any amount and until September 4 had never received a single demand for payment from Valeant. R&O has requested copies of the invoices, but to no avail. Indeed, it seems that Valeant has no evidence whatsoever to back up its claims. Therefore, R&O believes that one of two things must be true: 1. Valeant and R&O are victims of a massive fraud perpetuated by third parties; or 2. Valeant is conspiring with other persons or entities to perpetuate a massive fraud against R&O and others. — R&O Pharmacy LLC Complaint for Declaratory Judgment", "attrs": null, "subkind": null, "toolName": "Authority citation", "toolSlug": "authority-citation", "confidence": null, "componentId": "019dd953-70f7-7334-b228-c0762e7f58f0", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.65, "x": 0.04, "y": 0.08 }, "kind": "title", "text": "Recent Facts Discredit R&O's Narrative", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "2f070ad6-6802-4b8c-9008-8080cd57ae13", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [ { "name": "fraud-exposure", "slug": null, "matchId": "739f84ef-56fd-47b8-88df-5fc873c58d28", "evidence": "The slide explicitly frames the narrative as exposing a contradiction and potential fraud.", "confidence": 0.9 } ], "arcBeats": [ { "to": 16, "from": 10, "beatId": "8c9c2453-1cf4-4b69-b170-2662e00c1f90", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "Presentation of facts and data to support Valeant's position", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }